Bill Meagher's focus with The Deal is on small and microcap equity finance, healthcare and biotechnology, PIPEs, and companies going public. His work has appeared in newspapers and magazines throughout California as well as on PBS, “60 Minutes,” ABC News and CNBC. Meagher has also written video scripts and produced national events for a non-profit educational organization and ghost written two books.
While President Trump pledged last month that pharma companies would decide to voluntarily aggress to 'massive' drops in drug prices, clearly nobody told Pfizer.
The DOJ made a bust tied to fraud and opioids totaling $2 billion after the FDA held a hearing asking companies like Google and Twitter for help dealing with online opioid sales.
In 2016, 42,000 Americans died from opioid overdoses. The FDA wants illegal online sales of the drugs halted, and is looking towards tech companies to do some of the lifting.
An FDA summit focusing on how easy it is to score opioids online will mostly be offline keeping companies like Facebook and Google from having to answer questions in a public way.
Despite a growing trade war between the U.S, and China, drug officials in that country have pledged to try to stop the flow of fentanyl into the U.S.
Insulin has been around since 1921. But there is no generic drug and four companies control the market. Now politicians, the AMA and patient groups are looking for lower prices.
After Purdue let some of its sales staff go in February, it followed up June 20 by sending the rest of the staff packing.
The Duchenne Muscular Dystrophy specialist announces early results that show a gene-based treatment for the debilitating disease may be just two years away.
While the CREATES ACT passed out of committee in the Senate, Senator Orrin Hatch, who helped pave the way for generic drugs in the U.S,,voted against the measure.
The health and human services secretary calls for getting rid of rebates between pharmacy benefit managers and drug companies, but senators had plenty of other issues with the Trump administration's blueprint to lower drug prices.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.